APA (7th ed.) Citation

Hoogeveen, R. M., Verweij, S. L., Kaiser, Y., Kroon, J., Verberne, H. J., Vogt, L., . . . Stroes, E. S. G. (2021). Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Nature Portfolio.

Chicago Style (17th ed.) Citation

Hoogeveen, Renate M., Simone L. Verweij, Yannick Kaiser, Jeffrey Kroon, Hein J. Verberne, Liffert Vogt, Sophie J. Bernelot Moens, and Erik S. G. Stroes. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Hoogeveen, Renate M., et al. Atorvastatin Treatment Does Not Abolish Inflammatory Mediated Cardiovascular Risk in Subjects with Chronic Kidney Disease. Nature Portfolio, 2021.